Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CTNNB1 | P35222 | 4/20 | 0.38 |
| ▸ | WNT3A | P56704 | 3/20 | 0.38 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | TNF | P01375 | 1/20 | 0.35 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.35 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.35 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.35 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29689910 | 0.85 | NPC1 (0.42) | SMN1; SMN2NPC1TP53RAB9ACTNNB1 | |
| SCHEMBL24443482 | 0.85 | NPC1 (0.42) | SMN1; SMN2NPC1TP53RAB9ACTNNB1 | |
| SCHEMBL15672500 | 0.83 | POLB (0.37) | SMN1; SMN2NPC1TP53RAB9AKMT2A | |
| SCHEMBL17079522 | 0.83 | ALDH1A1 (0.44) | SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL15672498 | 0.81 | SMN1; SMN2 (0.38) | SMN1; SMN2ALDH1A1L3MBTL1KMT2ASSTR4 | |
| SCHEMBL15282516 | 0.81 | TSHR (0.40) | SMN1; SMN2RAB9AALDH1A1L3MBTL1KMT2A | |
| SCHEMBL17005191 | 0.81 | L3MBTL1 (0.45) | SMN1; SMN2NPC1RAB9ACTNNB1WNT3A | |
| SCHEMBL29689474 | 0.80 | SMN1; SMN2 (0.44) | SMN1; SMN2NPC1TP53RAB9ACTNNB1 | |
| SCHEMBL24443475 | 0.80 | SMN1; SMN2 (0.44) | SMN1; SMN2NPC1TP53RAB9ACTNNB1 | |
| SCHEMBL15672497 | 0.79 | SMN1; SMN2 (0.38) | SMN1; SMN2ALDH1A1L3MBTL1SSTR4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2912041-B1 | TETRAHYDROPYRROLOTHIAZINE DERIVATIVES AS BACE INHIBITORS | LILLY CO ELI (US) | 2016-12-14 | — | — | EP | disclosed |
| US-9328124-B2 | BACE inhibitors | ELI LILLY AND COMPANY (US) | 2016-05-03 | — | — | US | disclosed |
| US-20150232483-A1 | BACE INHIBITORS | ELI LILLY AND COMPANY | 2015-08-20 | — | — | US | disclosed |
| WO-2014066132-A1 | BACE INHIBITORS | ELI LILLY AND COMPANY (US) | 2014-05-01 | — | — | WO | disclosed |
| WO-2014013076-A1 | HEXAHYDROPYRROLOTHIAZINE COMPOUNDS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2014-01-23 | — | — | WO | disclosed |
| WO-2014013076-A1 | HEXAHYDROPYRROLOTHIAZINE COMPOUNDS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2014-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232483-A1 | BACE INHIBITORS | BACE1, BACE2, APP | SMN1; SMN2 1298/4885NPC1 18/4885TP53 2451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.